95 related articles for article (PubMed ID: 24743335)
1. Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancer.
Chen Z; Chen X; Zhou E; Chen G; Qian K; Wu X; Miao X; Tang Z
PLoS One; 2014; 9(4):e95475. PubMed ID: 24743335
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic significance of CD8
Al-Saleh K; Abd El-Aziz N; Ali A; Abozeed W; Abd El-Warith A; Ibraheem A; Ansari J; Al-Rikabi A; Husain S; Nabholtz JM
Oncol Lett; 2017 Jul; 14(1):337-344. PubMed ID: 28693173
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and prognostic significance of casting-type calcifications in patients with invasive breast cancer presenting with microcalcification.
Wang J; Zhao L; Hu X; Lv L; Zhang X; Lu M; Hu G
Sci Rep; 2024 Jun; 14(1):13351. PubMed ID: 38858542
[TBL] [Abstract][Full Text] [Related]
4. Effects of clinicopathological factors on prognosis of young patients with resected breast cancer.
Li W; Deng Y; Wu Q; Chen W; Liu Z; Wang T; Ai C; Chen F; Wang Z; Ma G; Zhou Q
Medicine (Baltimore); 2021 Feb; 100(5):e23693. PubMed ID: 33592828
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Values of CD8+, PARP, and EGFR on Overall Survival in Patients with Triple-Negative Breast Cancer.
Putri RI; Haryono SJ; Brahma B; Prayitno YH; Sutandyo N
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1025-1034. PubMed ID: 38546085
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of Gli1 expression in breast cancer: a meta-analysis.
Wang B; Yu T; Hu Y; Xiang M; Peng H; Lin Y; Han L; Zhang L
Oncotarget; 2017 Oct; 8(46):81088-81097. PubMed ID: 29113369
[TBL] [Abstract][Full Text] [Related]
7. Stromal B Lymphocytes Affecting Prognosis in Triple-Negative Breast Cancer by Opal/TSA Multiplexed Immunofluorescence.
Fang M; Yin W; Qiu C; Song T; Lin B; Wang Y; Xiong H; Wu S
Int J Womens Health; 2024; 16():755-767. PubMed ID: 38706691
[TBL] [Abstract][Full Text] [Related]
8. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
9. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.
Gandhi S; Opyrchal M; Grimm MJ; Slomba RT; Kokolus KM; Witkiewicz A; Attwood K; Groman A; Williams L; Tarquini ML; Wallace PK; Soh KT; Minderman H; Maguire O; O'Connor TL; Early AP; Levine EG; Kalinski P
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963636
[TBL] [Abstract][Full Text] [Related]
10. Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients.
Chivu-Economescu M; Herlea V; Dima S; Sorop A; Pechianu C; Procop A; Kitahara S; Necula L; Matei L; Dragu D; Neagu AI; Bleotu C; Diaconu CC; Popescu I; Duda DG
Gastric Cancer; 2023 Nov; 26(6):934-946. PubMed ID: 37668884
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD8
Sun YP; Ke YL; Li X
Oncol Lett; 2023 Jan; 25(1):39. PubMed ID: 36589661
[TBL] [Abstract][Full Text] [Related]
12. Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.
Spathas N; Goussia AC; Koliou GA; Gogas H; Zagouri F; Batistatou A; Charchanti AV; Papoudou-Bai A; Bobos M; Chrisafi S; Chatzopoulos K; Kostopoulos I; Koletsa T; Arapantoni P; Pectasides D; Galani E; Koutras A; Zarkavelis G; Saloustros E; Bafaloukos D; Karanikiotis C; Bompolaki I; Aravantinos G; Psyrri A; Razis E; Koumarianou A; Res E; Linardou H; Fountzilas G
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428728
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients.
Radziuviene G; Rasmusson A; Augulis R; Grineviciute RB; Zilenaite D; Laurinaviciene A; Ostapenko V; Laurinavicius A
Front Oncol; 2021; 11():774088. PubMed ID: 34858854
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
Berele BA; Cai Y; Yang G
Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
[TBL] [Abstract][Full Text] [Related]
15. M6A "Writer" Gene
Cai C; Long J; Huang Q; Han Y; Peng Y; Guo C; Liu S; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
Front Oncol; 2021; 11():615296. PubMed ID: 34221955
[TBL] [Abstract][Full Text] [Related]
16. CD8 Positive T Lymphocyte Infiltration of Liver Metastases of Uveal Melanoma: A Case Report.
Takahashi N; Tajiri K; Kagoyana K; Tanaka S; Yasuda I
Front Oncol; 2021; 11():672660. PubMed ID: 34150638
[TBL] [Abstract][Full Text] [Related]
17. NFκB-Activated COX2/PGE
Ibrahim OM; Basse PH; Jiang W; Guru K; Chatta G; Kalinski P
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809455
[TBL] [Abstract][Full Text] [Related]
18. Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients.
Smolkova B; Cierna Z; Kalavska K; Miklikova S; Plava J; Minarik G; Sedlackova T; Cholujova D; Gronesova P; Cihova M; Majerova K; Karaba M; Benca J; Pindak D; Mardiak J; Mego M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322711
[TBL] [Abstract][Full Text] [Related]
19. Role of tumor microenvironment in the efficacy of BCG therapy.
Ibrahim OM; Pandey RK; Chatta G; Kalinski P
Trends Res; 2020 Oct; 3(4):. PubMed ID: 33178990
[TBL] [Abstract][Full Text] [Related]
20. Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8
Shuai C; Yang X; Pan H; Han W
Front Oncol; 2020; 10():582863. PubMed ID: 33102239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
